COMMUNIQUÉS West-GlobeNewswire

Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the [...]
CFN Media Launches Inaugural Episode of CFN Weekly
23/07/2018
SEATTLE, July 23, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the launch of a new weekly news show [...]
MedTainer Orders Continue to Grow; More LPs Choosing Acology
23/07/2018
CORONA, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that orders for its signature product, the MedTainer™, continue to increase beyond the record pace set for the same [...]
Allena Pharmaceuticals Announces First Patients Treated in Phase 2 Basket Study of ALLN-177 in Patients with Primary Hyperoxaluria or Enteric Hyperoxaluria and Advanced Chronic Kidney Disease
23/07/2018
U.S. Clinical Study Sites Enrolling Patients with Systemic Oxalate Burden; European Sites Prepared to Enroll Patients in Third Quarter of 2018 NEWTON, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc [...]
Brooke Donaldson, MD is Appointed to the American Health Council’s Board of Physicians
23/07/2018
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Brooke Donaldson, MD has been appointed to the American Health Council’s Board of Physicians. Dr. Donaldson currently serves as the Genesis Peer Support clinical chairwoman, [...]
Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers
23/07/2018
Phase 1/2 Studies will Evaluate the Combination of Imfinzi® (Durvalumab) and Sacituzumab Govitecan in Previously-Untreated Patients with Triple-negative Breast Cancer and Urothelial Cancer MORRIS PLAINS, N.J., July 23, [...]
PetMed Express D/B/A 1-800-PetMeds Announces Record Earnings for Its First Fiscal Quarter and Its Increased Quarterly Dividend of $0.27 Per Share
23/07/2018
First Quarter Net Income Increased 36% First Quarter Sales Increased 10% First Quarter Diluted EPS $0.62 per share vs $0.45 per share DELRAY BEACH, Fla., July 23, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: [...]
Savara to Ring Nasdaq Stock Market Opening Bell on July 23rd
23/07/2018
AUSTIN, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, announced today that Rob Neville, CEO of Savara, alongside key members of senior management, company directors [...]
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
23/07/2018
Data from the First Patient Cohort Indicate CRV431 is Safe and Well Tolerated EDISON, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the [...]
Tabula Rasa HealthCare’s SinfoníaRx Releases RxCompanion™ 10.0 Software
23/07/2018
Enhances User Experience to Maximize Outcomes MOORESTOWN, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, today [...]
Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
23/07/2018
-- Program Offers Enhanced Support for Development of Medicines that Target Unmet Medical Needs -- BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company [...]
Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced it has entered into a [...]
Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
23/07/2018
BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
RedHill Biopharma Announces Uplisting to Nasdaq Global Market
23/07/2018
TEL-AVIV, Israel and RALEIGH, N.C., July 23, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology Market in United States
23/07/2018
23 July 2018 Midatech Pharma PLC (“Midatech”, “Company” or “Group”) Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology [...]
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2018 Annual Shareholder Meeting
23/07/2018
NEWTOWN, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (Nasdaq:HSDT) (“ Helius ” or the “ Company ”) announced today the results of the matters submitted for voting at the annual [...]
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone
23/07/2018
Company Provides Pipeline Enrollment Update for Clinical Trials in Inherited Retinal Diseases GAINESVILLE, Fla. and CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: [...]
Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
23/07/2018
SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced the achievement of key milestones as part of its agreement with Cystic Fibrosis [...]
Epizyme Appoints Dr. Shefali Agarwal as Chief Medical Officer
23/07/2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the appointment of Dr. Shefali Agarwal as chief medical [...]

Pages